Bloodstream infections and clinical significance of healthcareassociated bacteremia: A multicenter surveillance study in korean hospitals

Journal of Korean Medical Science

Volumn 25, Issue 7, 2010, Pages 992-998

  Son, Jun Seong ^a   Song, Jae Hoon ^b,k   Ko, Kwan Soo ^b,k   Yeom, Joon Sup ^c   Ki, Hyun Kyun ^d   Kim, Shin Woo ^e   Chang, Hyun Ha ^e   Ryu, Seong Yeol ^f   Kim, Yeon Sook ^g   Jung, Sook In ^h   Shin, Sang Yop ⁱ   Oh, Hee Bok ^j   Lee, Yeong Seon ^j   Chung, Doo Ryeon ^b   Lee, Nam Yong ^b   Peck, Kyong Ran ^b  

^a Kyung Hee University College of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Konkuk University Hospital   (South Korea)

^e Kyungpook National University Hospital   (South Korea)

^f Dongsan Medical Center   (South Korea)

^g Chungnam National University College of Medicine   (South Korea)

^h Chonnam National University Medical School   (South Korea)

ⁱ Jeju National University   (South Korea)

^j Korea Centers for Disease Control and Prevention   (South Korea)

^k Samsung Medical Center   (South Korea)

more..

Author keywords

Bacteremia; Bloodstream infection; Community acquired; Healthcare associated; Hospitalacquired

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; BACTEREMIA; CLINICAL TRIAL; COMMUNICABLE DISEASE; CROSS INFECTION; HUMAN; KOREA; MALE; MICROBIOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME; COMMUNITY-ACQUIRED INFECTIONS; YOUNG ADULT;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; HUMANS; KOREA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77956537400     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2010.25.7.992     Document Type: Article

References (23)

1. Leibovici L, Samra Z, Konigsberger H, Drucker M, Ashkenazi S, Pitlik SD. Long-term survival following bacteremia or fungemia. JAMA 1995; 274: 807-12.
2. Pedersen G, Schønheyder HC, Sørensen HT. Source of infection and other factors associated with case fatality in community-acquired bacteremia- a Danish population-based cohort study from 1992 to 1997. Clin Microbiol Infect 2003; 9: 793-802.
3. Friedman ND, Kaye KS, Stout JE, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ. Healthcare-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002; 137: 791-7.
4. Siegman-Igra Y, Fourer B, Orni-Wasserlauf R, Golan Y, Noy A, Schwartz D, Giladi M. Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia. Clin Infect Dis 2002; 34: 1431-9.
5. Shorr AF, Tabak YP, Killian AD, Gupta V, Liu LZ, Kollef MH. Healthcareassociated bloodstream infection: a distinct entity? Insights from a large U.S. database. Crit Care Med 2006; 34: 2588-95.
6. Weinstein MP, Towns ML, Quartey SM, Mirrett S, Reimer LG, Parmigiani G, Reller LB. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997; 24: 584-602.
7. Lark RL, Chenoweth C, Saint S, Zemencuk JK, Lipsky BA, Plorde JJ. Four year prospective evaluation of nosocomial bacteremia: epidemiology, microbiology, and patient outcome. Diagn Microbiol Infect Dis 2000; 38: 131-40.
8. Lark RL, Saint S, Chenoweth C, Zemencuk JK, Lipsky BA, Plorde JJ. Fouryear prospective evaluation of community-acquired bacteremia: epidemiology, microbiology, and patient outcome. Diagn Microbiol Infect Dis 2001; 41: 15-22.
9. McDonald JR, Friedman ND, Stout JE, Sexton DJ, Kaye KS. Risk factors for ineffective therapy in patients with bloodstream infection. Arch Intern Med 2005; 165: 308-13.
10. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 1995; 273: 117-23.
11. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-74.
12. Chow JW, Yu VL. Combination antibiotic versus monotherapy for gramnegative bacteremia: a commentary. Int J Antimicrob Agents 1999; 11: 7-12.
13. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 2005; 49: 760-6.
14. Kasiakou SK, Michalopoulos A, Soteriades ES, Samonis G, Sermaides GJ, Falagas ME. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Antimicrob Agents Chemother 2005; 49: 3136-46.
15. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement. Wayne, PA: CLSI, 2005. Document No. M100-S15.
16. Cheong HS, Kang CI, Kwon KT, Heo ST, Wi YM, Kim ES, Lee JS, Ko KS, Chung DR, Lee NY, Song JH, Peck KR. Clinical significance of healthcareassociated infections in community-onset Escherichia coli bacteraemia. J Antimicrob Chemother 2007; 60: 1355-60.
17. Kang CI, Cheong HS, Chung DR, Peck KR, Song JH, Oh MD, Choe KW. Clinical features and outcome of community-onset bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Eur J Clin Microbiol Infect Dis 2008; 27: 85-8.
18. Lesens O, Hansmann Y, Brannigan E, Hopkins S, Meyer P, O'Connel B, Prévost G, Bergin C, Christmann D. Healthcare-associated Staphylococcus aureus bacteremia and the risk for methicillin resistance: is the Center for Disease Control and Prevention definition for community acquired bacteremia still appropriate? Infect Control Hosp Epidemiol 2005; 26: 204-9.
19. Ramphal R. Importance of adequate initial antimicrobial therapy. Chemotherapy 2005; 51: 171-6.
20. Du B, Long Y, Liu H, Chen D, Liu D, Xu Y, Xie X. Extended spectrum betalactamase- producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome. Intensive Care Med 2002; 28: 1718-23.
21. Elhanan G, Sarhat M, Raz R. Empiric antibiotic treatment and the misuse of culture results and antibiotic sensitivities in patients with communityacquired bacteraemia due to urinary tract infection. J Infect 1997; 35: 283-8.
22. Byl B, Clevenbergh P, Jacobs F, Jacobs F, Struelens MJ, Zech F, Kentos A, Thys JP. Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis 1999; 29: 60-6.
23. Pazos Añón R, Fernández Rodríguez R, Paz Vidal I, Tinajas A, Cantón I, Abel V, González R, Martínez R, Gayoso P, Fernández Alvarez O. Prognostic factors of bacteremia: prospective study. An Med Interna 2001; 18: 415-20.